Bankrupt and weary, diet pill maker Orexigen to sell for $75M to Nal...
04/23/18
![]()
Bankrupt and weary, diet pill maker Orexigen to sell for $75M to Nalpropion
Endpoints News
Back in 2017, CEO Michael Narachi told me he hoped a merger or sale would get the company back on track with the ability to share costs with another organization. Then last month Orexigen announced a Chapter 11 bankruptcy in a last-ditch effort to ...
Orexigen, seller of weight-loss drug Contrave, agrees to sale for $75 millionThe San Diego Union-Tribune
Pernix Therapeutics Announces Participation in Lead Bid for Acquisition of Worldwide Rights to Contrave® for Weight ...GlobeNewswire (press release)
Orexigen Therapeutics, Inc. Enters Agreement for Sale of CompanyBenzinga
all 9 news articles »
[more]
Endpoints News
Back in 2017, CEO Michael Narachi told me he hoped a merger or sale would get the company back on track with the ability to share costs with another organization. Then last month Orexigen announced a Chapter 11 bankruptcy in a last-ditch effort to ...
Orexigen, seller of weight-loss drug Contrave, agrees to sale for $75 millionThe San Diego Union-Tribune
Pernix Therapeutics Announces Participation in Lead Bid for Acquisition of Worldwide Rights to Contrave® for Weight ...GlobeNewswire (press release)
Orexigen Therapeutics, Inc. Enters Agreement for Sale of CompanyBenzinga
all 9 news articles »